Literature DB >> 3052941

Specificity of anti-lymphocyte antibodies in sera from patients with AIDS-related complex (ARC) and healthy homosexuals.

R Q Warren1, E A Johnson, R P Donnelly, M F Lavia, K Y Tsang.   

Abstract

The presence and specificity of anti-lymphocyte antibodies (ALA) was investigated in sera from male homosexuals with AIDS-Related Complex (ARC) as well as healthy homosexuals. Individuals in the healthy homosexual group had no detectable antibodies to human immunodeficiency virus (HIV). Antibodies reactive with normal peripheral blood mononuclear cells were detected by Western blot analysis in sera from both groups of homosexuals. Of those individuals whose sera contained ALA, 71% of ARC patients and 83% of healthy homosexuals had antibodies recognizing a 73 kilodalton (kD) molecule. ALA present in ARC sera reacted with CD3+, CD4+ and CD8+ lymphocytes while little reactivity with B cells was observed. Our results indicate that ALA appear in homosexuals prior to HIV infection and are reactive primarily with T lymphocytes. A 73 kD structure associated with the T cell membrane is frequently the target for these antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3052941      PMCID: PMC1541601     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane.

Authors:  B Perussia; O Acuto; C Terhorst; J Faust; R Lazarus; V Fanning; G Trinchieri
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

2.  Immunoglobulin isotype expression of normal pre-B cells as determined by immunofluorescence.

Authors:  H Kubagawa; W E Gathings; D Levitt; J F Kearney; M D Cooper
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

3.  Serum suppression of lymphocyte activation in vitro in acquired immunodeficiency disease.

Authors:  S Cunningham-Rundles; M A Michelis; H Masur
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

4.  Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors:  C Sundström; K Nilsson
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

5.  Cross-reactivity of sperm and T lymphocyte antigens.

Authors:  S Mathur; J M Goust; H O Williamson; H H Fudenberg
Journal:  Am J Reprod Immunol       Date:  1981       Impact factor: 3.886

6.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells.

Authors:  R B Stricker; T M McHugh; D J Moody; W J Morrow; D P Stites; M A Shuman; J A Levy
Journal:  Nature       Date:  1987 Jun 25-Jul 1       Impact factor: 49.962

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  8 in total

Review 1.  Molecular immunopathogenesis of HIV infection.

Authors:  T T Ng; A J Pinching; C Guntermann; W J Morrow
Journal:  Genitourin Med       Date:  1996-12

2.  Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.

Authors:  M Kowalski; B Ardman; L Basiripour; Y C Lu; D Blohm; W Haseltine; J Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  Unique ligand-binding property of the human IgM Fc receptor.

Authors:  Kazuhito Honjo; Yoshiki Kubagawa; John F Kearney; Hiromi Kubagawa
Journal:  J Immunol       Date:  2015-01-19       Impact factor: 5.422

4.  Differential isotype expression and binding properties of T cell-reactive antibodies in human immunodeficiency virus (HIV) infection.

Authors:  F Silvestris; C Azzolini; F Dammacco
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

5.  Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation.

Authors:  A Shirai; M Cosentino; S F Leitman-Klinman; D M Klinman
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

6.  Immunosuppressive human anti-lymphocyte autoantibodies specific for the type 1 sphingosine 1-phosphate receptor.

Authors:  Jia-Jun Liao; Mei-Chuan Huang; Katharine Fast; Katherine Gundling; Mahesh Yadav; James R Van Brocklyn; Matthias R Wabl; Edward J Goetzl
Journal:  FASEB J       Date:  2009-01-21       Impact factor: 5.191

7.  Cross-linking of Fas by antibodies to a peculiar domain of gp120 V3 loop can enhance T cell apoptosis in HIV-1-infected patients.

Authors:  F Silvestris; S Nagata; P Cafforio; N Silvestris; F Dammacco
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

8.  Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes.

Authors:  B Ardman; M A Sikorski; M Settles; D E Staunton
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.